Mitera S.A. — Clinical Trial Site

18 Registered trials

12 Currently recruiting

Organisation

Mitera S.A.

Location

Marousi, Greece

Identifier

ORG-100045420

Address

Erythrou Stavrou Str 6, 151 23, Greece

Departments

2nd Department of Medical Oncology
2nd Medical Oncology Department
30001: Ocular Oncology Adult and Children Department
Adult Cardiology Clinic
Artificial Kidney Unit
Cardiology Clinic
Children's - Adolescent's Oncology Clinic
Children's - Adolescent's Oncology Clinic HYGEIA-MITERA
Children's and Adolescents' Clinic
Oncology clinic
Oncology Department
Paediatric Cardiology and Congenital Heart Disease

Clinical trials at this site (18)

Search interface

ALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia Pending

2024-513824-41-00 Childhood non-mature-B Acute Lymphoblastic Leukemia 6
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham… Recruiting

2023-504655-27-00 Primary Indeterminate Lesions or Small Choroidal Melano 5 2024-12-23
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
Trial of T-DXd Versus SoC Chemotherapy as Adjuvant Treatment in Endometrial Cancer Recruiting

2024-519444-33-00 HER2-expressing endometrial cancer (IHC 3+/2+) 5 2026-03-12
A proof of concept study to evaluate treatments´efficacy by monitoring Minimal Residual Disease using ctDNA in HR-positive/HER2-negative ear… Recruiting

2023-505661-89-00 Early-stage, Hormone Receptor (HR)-positive / Human Epi 4 2025-12-19
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
A clinical trial to be conducted in many hospitals and in different countries with the medicinal substance Regadenoson to be used in a type … Recruiting

2024-515244-22-00 Patients who need to undergo a clinically indicated pha 9 2024-09-09
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer After Platinum-Based Chemother… Ended

2024-511957-23-00 Recurrent or Persistent Endometrial Cancer 5 2025-01-03
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 10 2024-10-09
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Halted

2022-500783-35-00 Acute Myeloid Leukemia 5 2022-12-06
Comparison of the effectiveness of IntraVenous FLECainide plus oral ranolazine versus intravenous flecainide alone in the cardioversion of r… Ended

2024-514677-22-00 Restoration of sinus rhythm in patients with recent AF 5 2023-03-23
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24